-+ 0.00%
-+ 0.00%
-+ 0.00%

CO-DIAGNOSTICS AND READYGO COLLABORATE TO EVALUATE BLOOD-BASED MOLECULAR TESTING AT THE POINT OF NEED, STARTING WITH EBOLA

Reuters·09/16/2026 12:47:17